Risk of venous thromboembolism in ankylosing spondylitis: a general population-based study
暂无分享,去创建一个
Hyon K. Choi | J. Esdaile | J. Aviña-Zubieta | E. C. Sayre | J. A. Aviña-Zubieta | M. D. de Vera | J. Chan | J. Aviña-Zubieta
[1] Daniel B. Shin,et al. Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study , 2018, European heart journal.
[2] L. Jacobsson,et al. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study , 2017, Arthritis Research & Therapy.
[3] Hyon K. Choi,et al. The Risk of Deep Venous Thrombosis and Pulmonary Embolism in Primary Sjögren Syndrome: A General Population-based Study , 2017, The Journal of Rheumatology.
[4] Linda C. Li,et al. Public opinion on community-based education and exercise programs for managing hip and knee osteoarthritis-like symptoms: results of a survey , 2016, Patient preference and adherence.
[5] Hyon K. Choi,et al. Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population‐Based Study , 2016, Arthritis care & research.
[6] Linda C. Li,et al. Femoroacetabular impingement and osteoarthritis of the hip. , 2015, Canadian family physician Medecin de famille canadien.
[7] Hyon K. Choi,et al. The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study. , 2015, Seminars in arthritis and rheumatism.
[8] Jenny Leese,et al. Rheumatologists’ Views and Perceived Barriers to Using Patient Decision Aids in Clinical Practice , 2015, Arthritis care & research.
[9] J. Paterson,et al. Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality , 2015, Annals of Internal Medicine.
[10] M. González-Gay,et al. Anti-TNF-α therapy reduces endothelial cell activation in non-diabetic ankylosing spondylitis patients , 2015, Rheumatology International.
[11] C Allyson Jones,et al. Emerging Role of Quality Indicators in Physical Therapist Practice and Health Service Delivery , 2015, Physical Therapy.
[12] S. Schneeweiss,et al. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs. , 2015, The American journal of medicine.
[13] Hyon K. Choi,et al. The risk of deep venous thrombosis and pulmonary embolism in giant cell arteritis: a general population-based study , 2014, Annals of the rheumatic diseases.
[14] Hyon K. Choi,et al. Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study , 2014, Annals of the rheumatic diseases.
[15] D. Shi,et al. Comparison of Venous Thromboembolism after Total Hip Arthroplasty between Ankylosing Spondylitis and Osteoarthritis , 2014, BioMed research international.
[16] Michal Dolezel,et al. Erratum to “New Optical Methods for Liveness Detection on Fingers” , 2014, BioMed research international.
[17] S. Schneeweiss,et al. Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis , 2013, Arthritis care & research.
[18] M. Ghajarzadeh,et al. Successful Catheter-Directed Venous Thrombolysis in an Ankylosing Spondylitis Patient with Phlegmasia Cerulea Dolens , 2013, Iranian journal of radiology : a quarterly journal published by the Iranian Radiological Society.
[19] P. Voulgari,et al. Atherosclerosis and cardiovascular disease in the spondyloarthritides, particularly ankylosing spondylitis and psoriatic arthritis. , 2013, Clinical and experimental rheumatology.
[20] Hyon K. Choi,et al. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study , 2012, Annals of the rheumatic diseases.
[21] R. White. Identifying risk factors for venous thromboembolism. , 2012, Circulation.
[22] E. Horváth-Puhó,et al. Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population‐based case‐control study , 2012, Journal of thrombosis and haemostasis : JTH.
[23] M. Etminan,et al. Oral fluoroquinolones and the risk of retinal detachment. , 2012, JAMA.
[24] J. Sundquist,et al. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden , 2012, The Lancet.
[25] A. Levy,et al. Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. , 2011, Arthritis & Rheumatism.
[26] D. Symmons,et al. Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti‑TNF therapy: results from the British Society for Rheumatology Biologics Register , 2011, Annals of the rheumatic diseases.
[27] S. Schneeweiss,et al. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. , 2011, JAMA.
[28] P. Szodoray,et al. Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment. , 2011, Autoimmunity reviews.
[29] M. Abrahamowicz,et al. Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study , 2011, Annals of the rheumatic diseases.
[30] M. Abrahamowicz,et al. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study , 2011, Annals of the rheumatic diseases.
[31] Sreeram V Ramagopalan,et al. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study , 2011, BMC medicine.
[32] B. Dijkmans,et al. Signs of Accelerated Preclinical Atherosclerosis in Patients with Ankylosing Spondylitis , 2010, The Journal of Rheumatology.
[33] Zoran Bursac,et al. Purposeful selection of variables in logistic regression , 2008, Source Code for Biology and Medicine.
[34] J. Heit,et al. The epidemiology of venous thromboembolism in the community. , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[35] J. Singh,et al. Accuracy of the diagnoses of spondylarthritides in veterans affairs medical center databases. , 2007, Arthritis and rheumatism.
[36] C. Huerta,et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. , 2007, Archives of internal medicine.
[37] P. Romundstad,et al. Incidence and mortality of venous thrombosis: a population‐based study , 2007, Journal of thrombosis and haemostasis : JTH.
[38] S. Schneeweiss. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics , 2006, Pharmacoepidemiology and drug safety.
[39] P. Merkel,et al. Brief Communication: High Incidence of Venous Thrombotic Events among Patients with Wegener Granulomatosis: The Wegener's Clinical Occurrence of Thrombosis (WeCLOT) Study , 2005, Annals of Internal Medicine.
[40] J Crowley,et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.
[41] J. Jollis,et al. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. , 1993, Journal of clinical epidemiology.
[42] J. Nolla,et al. Antiphospholipid syndrome in patients with ankylosing spondylitis. , 1993, Journal of Rheumatology.
[43] J. Nolla,et al. [Antiphospholipid syndrome in patients with ankylosing spondylitis. Presentation of 2 cases]. , 1992, Medicina clínica (Ed. impresa).
[44] I. Lazareth,et al. Lupus anticoagulant and leg ulcers associated with ankylosing spondylitis. , 1991, The Journal of rheumatology.
[45] M. Abrahamowicz,et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. , 2013, Rheumatology.
[46] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.